Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2010
11/25/2010US20100297077 Novel aryl potassium channel blockers and uses thereof
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/24/2010EP2253624A2 A mixture of halogenated hydantoin compounds
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252592A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
11/24/2010EP2252591A1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010EP1233936B2 Process for preparing ambient temperature ionic liquids
11/24/2010CN101896469A Substituted hydantoins as MEK kinase inhibitors
11/24/2010CN101896468A Method for reprocessing mixtures containing imidazolium salts
11/24/2010CN101896467A Method for the production of disubstituted imidazolium salts
11/24/2010CN101891687A Method for synthesizing hypoxia imaging agent 18F-FMISO
11/24/2010CN101891686A Synthesizing method of N-beta-alanyl-(tau-methyl) histidine
11/24/2010CN101891685A Alkyl imidazole-L-proline salt chiral ionic liquid and preparation method thereof
11/24/2010CN101891684A Preparation method of 1-mesyl-2-imidazolidone
11/24/2010CN101890366A Cupric salt-containing catalyst system and application thereof
11/23/2010US7838685 novel complex lipid having a cationic functional group derived from an amino acid; useful as a component of a stable, safe and functional carrier of a substance having an efficacy in pharmaceutical drugs, reagents, cosmetics and the like
11/23/2010US7838684 Ionic liquids
11/23/2010US7838682 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
11/23/2010US7838681 Synthesis of substituted heterocyclic compounds
11/23/2010US7838679 Pyridinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/23/2010US7838545 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2404755C Imidazole carbenes
11/18/2010WO2010132629A1 Granular fabric softening compositions comprising a di-alkyl substituted imidazoline derivatives
11/18/2010WO2010131844A2 Method for producing biofuel using marine algae-derived galactan
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130718A1 Process for the preparation of a compound useful as an inhibitor of tafia
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292480 Process and intermediates for preparing integrase inhibitors
11/18/2010US20100292474 Di-alkyl substituted imidazoline derivatives
11/18/2010US20100292465 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100288634 Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring
11/18/2010CA2761876A1 Haloalkyl heteroaryl benzamide compounds
11/18/2010CA2760748A1 Process for the preparation of a compound useful as an inhibitor of tafia
11/18/2010CA2757177A1 Di-alkyl substituted imidazoline derivatives
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250153A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
11/17/2010EP2249832A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP1989186B1 Hydantoin based kinase inhibitors
11/17/2010EP1491206B1 Use of peptide derivatives for inducing cell differentiation
11/17/2010CN101889003A Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof
11/17/2010CN101889002A Method for producing precursors for l-3,4-dihydroxy-6-[18f]fluorophenylalanine and 2-[18f]fluoro-l-tyrosine and the a-methylated derivatives thereof, said precursor, and a method for producing l-3,4-dihydroxy-6-[18f]fluorophenylalanine and 2-[18f]fluoro-l-tyrosine and the a-methylated derivatives thereof from the precursor
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101885706A High-yield preparation method for imidazoline-ammonium-salt paper softener
11/17/2010CN101531635B Imidazoline asymmetrical bi-quaternary ammonium salt, method for preparing same and application thereof
11/17/2010CN101153024B Aryl substituted imidazoline-2-ketones derivant, producing method and uses of the same
11/16/2010US7834192 pyrazolium cation with fluorosulfonate or fluorosulfonylimide anions; use as solvents, catalysts
11/16/2010US7834189 Oxazolium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/16/2010US7833991 Amine compound and use thereof
11/16/2010CA2532714C Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
11/16/2010CA2404680C Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
11/11/2010WO2010128102A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010WO2010099518A3 Method for manufacture of 2-oxoimidazolidines
11/11/2010US20100286349 Novel complexes and method for synthesis of group 4 organometallics grafted on anions olefin oligomerization and polymerization method
11/11/2010US20100286219 1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders
11/11/2010US20100286212 Treating and Preventing Viral Infections
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/11/2010US20100286091 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment
11/11/2010US20100286024 Insulinotropic compounds and uses thereof
11/11/2010US20100285542 Catalyzed preparation of (meth)acrylates of n-hydroxyalkylated amides
11/11/2010CA2760464A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/10/2010EP1877365B1 Acetylene derivatives
11/10/2010CN1697650B Non-nucleoside reverse transcriptase inhibitors
11/10/2010CN1676514B 1-di-ester-base-3-alkyl imidazo ion liquid and its preparing method
11/10/2010CN101880260A Insecticidal ester compound and preparation and application thereof
11/10/2010CN101880243A Fluorocyanogen-containing pyrethroid compound and synthesis method and application thereof
11/10/2010CN101880211A Method for preparing sulfonyl ring thiourea from mono-sulfonyl diamine in aqueous phase
11/10/2010CN101241774B A compound electrolyte composition and its making method
11/09/2010US7829739 Phosphonium cations combined with any of three fluorinated sulfonated anions such as 1,1,2,2-tetrafluoroethanesulfonate, or N,N-bis(1,1,2,2-tetrafluoroethanesulfonyl)imide; useful as solvents and catalysts
11/09/2010US7829725 Triazolium cation and fluoroalkylsulfonate or fluoroalkylsulfonylimide anions; solvents, catalysts
11/09/2010US7829722 Ionic liquids
11/09/2010US7829710 pyrazinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/09/2010US7829706 Pyrimidinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/09/2010US7829704 Ionic liquids
11/09/2010US7829590 Polo-like kinase inhibitors such as 5-(5-Amino-2H-pyrazol-3-yl)-3-[1-(2-chloro-phenyl)-ethoxy]-thiophene-2-carboxylic acid amide, useful for treating or preventing autoimmune, inflammatory, proliferative or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829044 For (back) extracting rare earth metal ions from aqueous solutions
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010126978A1 Methods for the preparation of amphiphilic nitrogen containing imidazolinium derivative compounds
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125402A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010US20100280258 Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds
11/04/2010US20100280257 Process for the synthesis of organic compounds
11/04/2010US20100280248 Novel compounds that are useful for improving pharmacokinetics
11/04/2010US20100280246 Energy transfer dyes with enhanced fluorescence
11/04/2010US20100280088 Halosubstituted aryloxyalkylimidazolines for use as pesticides
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759083A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 345